Archive
Past newsletters of MDDR.
Loading the archive
Past newsletters of MDDR.
Past newsletters of MDDR.
Saturday, 29 August 2026
The Northern Territory parliament has passed voluntary assisted dying legislation by a conscience vote, making it the last Australian jurisd
Friday, 28 August 2026
Sublocade, a long-acting slow-release buprenorphine injection for opioid dependence, will leave the Australian market by the end of the year
Thursday, 27 August 2026
Following clarification of eligibility for non-traditional services, the RACGP released sixth-edition accreditation standards with stronger
Wednesday, 26 August 2026
The US Food and Drug Administration approved the first oral PCSK9 inhibitor to reduce LDL cholesterol. The approval marked the first time th
Tuesday, 25 August 2026
Australia’s 2026–30 tuberculosis strategy has set national priorities to strengthen TB management and reduce inequities in outcomes. Austral
Sunday, 23 August 2026
Medline is recalling certain neonatal and infant heated-wire breathing circuits due to failures involving the electrical connector. The reca
Saturday, 22 August 2026
Veterans’ allied health spending will be subject to a $5000 annual threshold from 1 July 2027, although the DVA will fund care above that am
Friday, 21 August 2026
A new Senate Select Committee on Women’s Health will investigate postpartum healthcare, fertility and women’s pain. Chaired by South Austral
Thursday, 20 August 2026
Australia’s universal COVID-19 vaccine program will end on 1 October, with funded vaccines moving to the National Immunisation Program and e
Wednesday, 19 August 2026
TGA testing confirmed melanotan II in five seized nasal spray bottles labelled ‘Pure Tans Triple Strength 30 MG’, with estimated amounts ran